These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21746829)

  • 21. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
    Afolabi TM; Nahata MC; Pai V
    Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 23. Opioids, respiratory function, and dyspnea.
    LeGrand SB; Khawam EA; Walsh D; Rivera NI
    Am J Hosp Palliat Care; 2003; 20(1):57-61. PubMed ID: 12568438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.
    Barnes H; McDonald J; Smallwood N; Manser R
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011008. PubMed ID: 27030166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined Effect of Opioids and Corticosteroids for Alleviating Dyspnea in Terminal Cancer Patients: A Retrospective Review.
    Maeda T; Hayakawa T
    J Pain Palliat Care Pharmacother; 2016 Jun; 30(2):106-10. PubMed ID: 27093633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial.
    Allard P; Lamontagne C; Bernard P; Tremblay C
    J Pain Symptom Manage; 1999 Apr; 17(4):256-65. PubMed ID: 10203878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palliative Care Physicians' Practice in the Titration of Parenteral Opioids for Dyspnea in Terminally Ill Cancer Patients: A Nationwide Survey.
    Mori M; Matsunuma R; Suzuki K; Matsuda Y; Watanabe H; Yamaguchi T
    J Pain Symptom Manage; 2019 Jul; 58(1):e2-e5. PubMed ID: 30999067
    [No Abstract]   [Full Text] [Related]  

  • 28. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?
    Johnson MJ; Abernethy AP; Currow DC
    J Pain Symptom Manage; 2012 Mar; 43(3):614-24. PubMed ID: 22285285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of short-acting opioids in the management of breathlessness: an evidence-based review.
    Hui D; Bruera E
    Curr Opin Support Palliat Care; 2020 Sep; 14(3):167-176. PubMed ID: 32701856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians.
    Yamaguchi T; Matsunuma R; Suzuki K; Matsuda Y; Mori M; Watanabe H
    J Pain Symptom Manage; 2019 Oct; 58(4):672-677.e2. PubMed ID: 31201876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using opioids to treat dyspnea in advanced COPD: attitudes and experiences of family physicians and respiratory therapists.
    Young J; Donahue M; Farquhar M; Simpson C; Rocker G
    Can Fam Physician; 2012 Jul; 58(7):e401-7. PubMed ID: 22798476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiologies of dyspnea explained: why might opioids relieve dyspnea and not hasten death?
    Pinna MÁ
    J Palliat Med; 2013 Jan; 16(1):5. PubMed ID: 23317318
    [No Abstract]   [Full Text] [Related]  

  • 33. Can we really say that nebulized morphine works?
    Lasheen W; Panneerselvam A; Davis MP
    J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
    [No Abstract]   [Full Text] [Related]  

  • 34. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
    Shinjo T; Okada M
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl for dyspnea relief.
    Glass E
    Oncol Nurs Forum; 1998 Sep; 25(8):1310. PubMed ID: 9766281
    [No Abstract]   [Full Text] [Related]  

  • 36. Dyspnea can be, and should be, effectively palliated with opioids.
    Bascom PB
    J Palliat Med; 2013 May; 16(5):465. PubMed ID: 23531025
    [No Abstract]   [Full Text] [Related]  

  • 37. Opioid utility for dyspnea in chronic obstructive pulmonary disease: a complicated and controversial story.
    Vozoris NT
    Ann Palliat Med; 2020 Mar; 9(2):571-578. PubMed ID: 31865744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic intervention for cancer-related dyspnea.
    Cuervo Pinna MA; Mota Vargas R; Redondo Moralo MJ; Correas MA
    J Clin Oncol; 2008 Sep; 26(25):4225; author reply 4226. PubMed ID: 18757344
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
    Luo N; Tan S; Li X; Singh S; Liu S; Chen C; Huang Z; Feng S; Lin Y; Lin Y; Cen H; Liang M; Chen M
    J Pain Symptom Manage; 2021 Jan; 61(1):198-210.e1. PubMed ID: 32730950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.
    Rocker G; Bourbeau J; Downar J
    J Palliat Med; 2018 Feb; 21(2):120-122. PubMed ID: 29393775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.